Global Addiction Treatment Market Report and Forecast 2023-2031

Global Addiction Treatment Market Report and Forecast 2023-2031

Global Addiction Treatment Market Outlook

The global addiction treatment market size attained a value of USD 6.8 billion in 2022. The market is expected to grow further at a CAGR of 6.1% during the forecast period of 2023-2031 to attain a value of nearly USD 11.7 billion by 2031. This growth can be attributed to the increasing prevalence of addiction and rising awareness about the importance of treatment.

Addiction Treatment Market: Introduction

Addiction is a complex brain disease characterized by compulsive drug use despite the harmful consequences. Addiction disorders can lead to a range of health issues, social problems, and economic burdens. Treatment for addiction disorders involves a combination of medication and behavioural therapies. The global addiction treatment market report by Expert Market Research provides an in-depth analysis of the market and its segments.

The market is expected to benefit from the increasing investment in research and development activities by key players in the industry. The development of novel therapies and the increasing focus on personalized medicine are likely to create new growth opportunities for the market players. Furthermore, the expanding healthcare infrastructure in emerging economies and the increasing demand for advanced diagnostic tools and treatment options are expected to contribute to the growth of the market.

Addiction Epidemiology

Addiction disorders are a significant public health issue worldwide. According to the World Health Organization, an estimated 35 million people worldwide suffer from drug use disorders. In the United States, the National Survey on Drug Use and Health estimates that 19.7 million adults (aged 18 or older) had a substance use disorder in 2017. Furthermore, addiction disorders can lead to a range of co-occurring mental health issues, such as depression and anxiety, which can further complicate the treatment process.

Addiction Treatment Market Segmentations

The market can be categorised into treatment type, addiction type, route of administration, treatment centres, treatment channels, and distribution channel.

Market Breakup by Treatment Type

• Medications
• Bupropion
• Varenicline
• Acamprosate
• Disulfiram
• Naltrexone
• Methadone
• Buprenorphine
• Nicotine Replacement Products
• Others
• Counselling and Behavioural Therapies
• Cognitive-Behavioural Therapy
• Multi-Dimensional Therapy
• Motivational
• Others
• Detoxifications
• Others

Market Breakup by Addiction Type

• Alcohol Addiction Treatment
• Tobacco/Nicotine Addiction Treatment
• Opioid Addiction Treatments
• Other Addictions

Market Breakup by Route of Administration

• Oral
• Parentals
• Others

Market Breakup by Treatment Centres

• Hospitals
• Specialty Clinics
• Homecare Settings
• Rehabilitation Centres
• Others

Market Breakup by Treatment Channel

• Public
• Private

Market Breakup by Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Market Breakup by Region

• North America
• United States of America
• Canada
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Asia Pacific
• China
• Japan
• India
• ASEAN
• Australia
• Others
• Latin America
• Brazil
• Argentina
• Mexico
• Others
• Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Addiction Treatment Market Scenario

The global addiction treatment market is expected to grow at a significant rate during the forecast period of 2023-2031. The increasing prevalence of addiction disorders, rising awareness about mental health, and growing investment in research and development activities are the key drivers of the market. North America dominates the market, followed by Europe and Asia Pacific. The leading players in the market are focusing on the development of new drugs and therapies and adopting various strategies to strengthen their position in the market.

North America dominates the addiction treatment market, followed by Europe and Asia Pacific. The high prevalence of addiction disorders in North America, coupled with the favourable reimbursement policies, is driving the growth of the market in the region. Europe is also a significant market for addiction treatment, with the presence of key players and increasing investment in research and development activities. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing awareness about addiction disorders and the rising healthcare expenditure in the region.

Key Players in the Global Addiction Treatment Market

The report gives an in-depth analysis of the key players involved in the Addiction Treatment Market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

• Takeda Pharmaceutical Company Limited
• F. Hoffmann-La Roche Ltd.
• Abbott
• Medtronic
• Abbott
• BD
• Johnson & Johnson Services, Inc.
• GSK Plc.
• Bayer AG
• Zimmer Biomet
• Stryker Corporation
• Homology Medicines, Inc.
• Novartis AG
• Pfizer Inc.
• JCR Pharmaceuticals Co., Ltd.
• Sangamo Therapeutics
• AVROBIO, Inc.
• REGENXBIO Inc.
• CANbridge Life Sciences Ltd.
• Denali Therapeutics